You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I follicular thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for

Recruiting
  • Thyroid Gland Follicular Carcinoma
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Pathological Manifestation in Thyroid Follicular Neoplasm: Early

Not yet recruiting
  • Thyroid Cancer
  • Follicular Thyroid Cancer
    • (no location specified)
    Jul 20, 2022

    Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

    Recruiting
    • Thyroid Cancer
    • +2 more
      • Taipei, Taiwan
        Chih-Yuan Wang, M.D
      Oct 16, 2022

      Studies on Tumors of the Thyroid

      Recruiting
      • Hurthle Cell Thyroid Cancer
      • +4 more
      • 68-Gallium Dotatate
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

      Active, not recruiting
      • Ann Arbor Stage I Grade 1 Follicular Lymphoma
      • +3 more
      • Clinical Observation
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

      Active, not recruiting
      • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
      • +11 more
      • Washington, District of Columbia
      • +6 more
      Feb 2, 2023

      Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

      Recruiting
      • Thyroid Cancer
      • +6 more
      • Basking Ridge, New Jersey
      • +6 more
      Jan 19, 2023

      Surgical Management of Advanced Thyroid Cancer

      Recruiting
      • Thyroid Carcinoma
      • +6 more
      • Thyroidectomy with or without lymphadenectomy or multivisceral resection
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 31, 2023

      18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

      Recruiting
      • Differentiated Thyroid Gland Carcinoma
      • +2 more
      • Computed Tomography
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

      Active, not recruiting
      • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • External Beam Radiation Therapy
      • Orbital Radiation
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Thyroid Cancer Trial in Suita (Targeted alpha therapy)

      Recruiting
      • Thyroid Cancer
      • Targeted alpha therapy
      • Suita, Japan
        Osaka University Hospital
      Mar 2, 2022

      Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

      Recruiting
      • Thyroid Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

      Recruiting
      • Ann Arbor Stage II Follicular Lymphoma
      • +5 more
      • Fresno, California
      • +2 more
      Jan 24, 2023

      Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

      Recruiting
      • Refractory Thyroid Gland Carcinoma
      • +3 more
      • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
      • +2 more
      • Xiamen, China
        The First Affiliated Hospital of Xiamen University
      Nov 3, 2022

      Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • +3 more
      • Larotrectinib monotherapy
      • 131I therapy
      • (no location specified)
      Mar 13, 2023

      Renal Tracer Elimination in Thyroid Cancer Patients Treated With

      Completed
      • Thyroid Carcinoma
        • Jena, Thüringen, Germany
          University Hospital Jena
        Dec 15, 2022

        Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)

        Not yet recruiting
        • Thyroid Neoplasm Follicular
        • Bone Metastases
        • Beijing, China
          Peking Union Medical College Hospital
        Jul 18, 2022

        Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

        Recruiting
        • Benign Thyroid Gland Neoplasm
        • +4 more
        • Quality-of-Life Assessment
        • Radiofrequency Ablation
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 3, 2022

        Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))

        Not yet recruiting
        • Thyroid Cancer
        • Bialystok, Poland
          Department of Endocrinology, Diabetology and Internal Medicine,
        Jul 26, 2022

        Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

        Active, not recruiting
        • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
        • +18 more
        • Anti-ICOS Monoclonal Antibody MEDI-570
        • +2 more
        • Duarte, California
        • +22 more
        Jan 18, 2023

        Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in

        Completed
        • Follicular Thyroid Cancer
        • Lectin-histochemistry retrospectively performed
        • Singapore, Singapore
          National University Hospital
        Sep 25, 2021

        BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

        Recruiting
        • BRAF NP_004324.2:p.V600M
        • +6 more
        • Portland, Oregon
          Providence Portland Medical Center
        Aug 17, 2022

        Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

        Recruiting
        • Thyroid Carcinoma
        • +5 more
        • I-124 PET/CT lesion dosimetry
        • +2 more
        • Basking Ridge, New Jersey
        • +6 more
        Mar 3, 2022